-
1دورية أكاديمية
المؤلفون: Forbes, AK, Hinton, W, Feher, MD, Elson, W, Ordóñez-Mena, JM, Joy, M, Fan, X, Banerjee, D, Cole, NI, Munro, N, Whyte, M, Suckling, RJ, Swift, PA, de Lusignan, S
وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
العلاقة: https://openaccess.sgul.ac.uk/id/eprint/116359/1/gfae071.pdfTest; https://openaccess.sgul.ac.uk/id/eprint/116359/6/gfae071_supplemental_file.docxTest; Forbes, AK; Hinton, W; Feher, MD; Elson, W; Ordóñez-Mena, JM; Joy, M; Fan, X; Banerjee, D; Cole, NI; Munro, N; et al. Forbes, AK; Hinton, W; Feher, MD; Elson, W; Ordóñez-Mena, JM; Joy, M; Fan, X; Banerjee, D; Cole, NI; Munro, N; Whyte, M; Suckling, RJ; Swift, PA; de Lusignan, S (2024) A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population. Nephrol Dial Transplant. ISSN 1460-2385 https://doi.org/10.1093/ndt/gfae071Test SGUL Authors: Banerjee, Debasish
الإتاحة: https://doi.org/10.1093/ndt/gfae071Test
https://openaccess.sgul.ac.uk/id/eprint/116359Test/
https://openaccess.sgul.ac.uk/id/eprint/116359/1/gfae071.pdfTest
https://openaccess.sgul.ac.uk/id/eprint/116359/6/gfae071_supplemental_file.docxTest -
2دورية أكاديمية
المؤلفون: Forbes, AK, Hinton, W, Feher, MD, Elson, W, Joy, M, Ordóñez-Mena, JM, Fan, X, Cole, NI, Banerjee, D, Suckling, RJ, de Lusignan, S, Swift, PA
وصف الملف: application/pdf
العلاقة: https://openaccess.sgul.ac.uk/id/eprint/116297/1/Implementation%20of%20chronic%20kidney%20disease%20guidelines%20for%20sodium-glucose%20co-transporter-2%20inhibitor%20use%20in%20primary%20care%20in%20the.pdfTest; https://openaccess.sgul.ac.uk/id/eprint/116297/6/1-s2.0-S2589537024000051-mmc1.pdfTest; Forbes, AK; Hinton, W; Feher, MD; Elson, W; Joy, M; Ordóñez-Mena, JM; Fan, X; Cole, NI; Banerjee, D; Suckling, RJ; et al. Forbes, AK; Hinton, W; Feher, MD; Elson, W; Joy, M; Ordóñez-Mena, JM; Fan, X; Cole, NI; Banerjee, D; Suckling, RJ; de Lusignan, S; Swift, PA (2024) Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study. EClinicalMedicine, 68. p. 102426. ISSN 2589-5370 https://doi.org/10.1016/j.eclinm.2024.102426Test SGUL Authors: Banerjee, Debasish
الإتاحة: https://doi.org/10.1016/j.eclinm.2024.102426Test
https://openaccess.sgul.ac.uk/id/eprint/116297Test/
https://openaccess.sgul.ac.uk/id/eprint/116297/1/Implementation%20of%20chronic%20kidney%20disease%20guidelines%20for%20sodium-glucose%20co-transporter-2%20inhibitor%20use%20in%20primary%20care%20in%20the.pdfTest
https://openaccess.sgul.ac.uk/id/eprint/116297/6/1-s2.0-S2589537024000051-mmc1.pdfTest